Leber congenital amaurosis 1
diseaseOn this page
Also known as amaurosis congenita of Leber, type 1CRBGUCY2D Leber congenital amaurosisLCALCA1Leber congenital amaurosis caused by mutation in GUCY2DLeber congenital amaurosis type 1
Summary
Leber congenital amaurosis 1 (MONDO:0008764) is a disease caused by GUCY2D (GenCC Definitive), with 13 cohort genes and 3 clinical trials. Top therapeutic interventions include polymyxin b, trimethoprim, and zuretinol acetate.
At a glance
- Causal gene: GUCY2D (GenCC Definitive)
- Cohort genes: 13
- ClinVar variants: 1,515
- Clinical trials: 3
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | Leber congenital amaurosis 1 |
| Mondo ID | MONDO:0008764 |
| OMIM | 204000 |
| DOID | DOID:0110078 |
| UMLS | C2931258 |
| MedGen | 419026 |
| GARD | 0000635 |
| Is cancer (heuristic) | no |
Also known as: amaurosis congenita of Leber, type 1 · CRB · GUCY2D Leber congenital amaurosis · LCA · LCA1 · Leber congenital amaurosis 1 · Leber congenital amaurosis caused by mutation in GUCY2D · Leber congenital amaurosis type 1
Data availability: 1,515 ClinVar variants · 3 GenCC gene-disease records.
Disease family
Classification path: disease › human disease › disease by body system or component › nervous system disorder › congenital nervous system disorder › Leber congenital amaurosis › Leber congenital amaurosis 1
Related subtypes (20): retinal aplasia, Leber congenital amaurosis 2, Leber congenital amaurosis 3, Leber congenital amaurosis 4, Leber congenital amaurosis 5, Leber congenital amaurosis 9, Leber congenital amaurosis 12, Leber congenital amaurosis 10, Leber congenital amaurosis 13, Leber congenital amaurosis 14, Leber congenital amaurosis 6, Leber congenital amaurosis 7, Leber congenital amaurosis 8, Leber congenital amaurosis 11, Leber congenital amaurosis 15, Leber congenital amaurosis 16, Leber congenital amaurosis 17, Leber congenital amaurosis 19, Leber congenital amaurosis with early-onset deafness, Leber congenital amaurosis 18
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
ClinVar germline variants
600 retrieved; paginated sample, class counts are floors:
289 uncertain significance, 241 likely benign, 24 pathogenic, 15 benign, 13 likely pathogenic, 11 conflicting classifications of pathogenicity, 5 pathogenic/likely pathogenic, 2 benign/likely benign
| ClinVar | Variant (HGVS) | Gene | Classification | Review |
|---|---|---|---|---|
| 1066142 | NM_000180.4(GUCY2D):c.-2_3del (p.Met1fs) | GUCY2D | Pathogenic | criteria provided, single submitter |
| 1069546 | NM_000180.4(GUCY2D):c.1361_1367del (p.Asn454fs) | GUCY2D | Pathogenic | criteria provided, single submitter |
| 1070768 | NM_000180.4(GUCY2D):c.2383C>T (p.Arg795Trp) | GUCY2D | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 1070769 | NM_000180.4(GUCY2D):c.2476C>T (p.Gln826Ter) | GUCY2D | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 1072504 | NM_000180.4(GUCY2D):c.484dup (p.Ala162fs) | GUCY2D | Pathogenic | criteria provided, single submitter |
| 1074833 | NM_000180.4(GUCY2D):c.2646C>G (p.Tyr882Ter) | GUCY2D | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 1075556 | NM_000180.4(GUCY2D):c.3105C>G (p.Tyr1035Ter) | GUCY2D | Pathogenic | criteria provided, single submitter |
| 1076325 | NM_000180.4(GUCY2D):c.564del (p.Ala189fs) | GUCY2D | Pathogenic | criteria provided, single submitter |
| 1184899 | NM_000180.4(GUCY2D):c.826del (p.Leu276fs) | GUCY2D | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1213843 | NM_000180.4(GUCY2D):c.1567-1G>C | GUCY2D | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1213844 | NM_000180.4(GUCY2D):c.690_693del (p.Lys232fs) | GUCY2D | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 1366687 | NM_000180.4(GUCY2D):c.2260G>T (p.Glu754Ter) | GUCY2D | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1413732 | NM_000180.4(GUCY2D):c.2871del (p.Ser958fs) | GUCY2D | Pathogenic | criteria provided, single submitter |
| 1454622 | NM_000180.4(GUCY2D):c.175del (p.Leu59fs) | GUCY2D | Pathogenic | criteria provided, single submitter |
| 1456503 | NM_000180.4(GUCY2D):c.2209C>T (p.Gln737Ter) | GUCY2D | Pathogenic | criteria provided, single submitter |
| 1459421 | NM_000180.4(GUCY2D):c.760G>T (p.Glu254Ter) | GUCY2D | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1685872 | NM_000180.4(GUCY2D):c.1A>G (p.Met1Val) | GUCY2D | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 1685873 | NM_000180.4(GUCY2D):c.2512C>G (p.Arg838Gly) | GUCY2D | Pathogenic | criteria provided, single submitter |
| 1687499 | NM_000180.4(GUCY2D):c.315C>A (p.Cys105Ter) | GUCY2D | Pathogenic | criteria provided, single submitter |
| 1915862 | NM_000180.4(GUCY2D):c.2678_2679del (p.Ser893fs) | GUCY2D | Pathogenic | criteria provided, single submitter |
| 198995 | NM_000180.4(GUCY2D):c.1773del (p.Asn591fs) | GUCY2D | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 2021991 | NM_000180.4(GUCY2D):c.860del (p.Pro287fs) | GUCY2D | Pathogenic | criteria provided, single submitter |
| 2046697 | NM_000180.4(GUCY2D):c.2323C>T (p.Gln775Ter) | GUCY2D | Pathogenic | criteria provided, single submitter |
| 2060321 | NM_000180.4(GUCY2D):c.781_782insT (p.Glu261fs) | GUCY2D | Pathogenic | criteria provided, single submitter |
| 2069382 | NM_000180.4(GUCY2D):c.3118_3125delinsAAGGTGAGGTAC (p.Arg1040fs) | GUCY2D | Pathogenic | criteria provided, single submitter |
| 2086516 | NM_000180.4(GUCY2D):c.1150del (p.Asp384fs) | GUCY2D | Pathogenic | criteria provided, single submitter |
| 2108666 | NM_000180.4(GUCY2D):c.1821_1824dup (p.Ala609fs) | GUCY2D | Pathogenic | criteria provided, single submitter |
| 2137915 | NM_000180.4(GUCY2D):c.1762C>T (p.Arg588Trp) | GUCY2D | Pathogenic | reviewed by expert panel |
| 2142901 | NM_000180.4(GUCY2D):c.2291del (p.Pro764fs) | GUCY2D | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1048129 | NM_000180.4(GUCY2D):c.929C>A (p.Thr310Asn) | GUCY2D | Likely pathogenic | criteria provided, single submitter |
Genes & proteins
Mendelian disease overlap and somatic drivers
GenCC: 12 · Orphanet: 31 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0
GenCC gene–disease validity (cohort genes)
the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.
| Gene | Classification | Inheritance | Disease | Records |
|---|---|---|---|---|
| GUCY2D | Definitive | Autosomal recessive | Leber congenital amaurosis 1 | 12 |
Orphanet rare-disease linkage (cohort genes)
| Gene | Orphanet ID | Rare disease |
|---|---|---|
| GUCY2D | Orphanet:1872 | Cone rod dystrophy |
| GUCY2D | Orphanet:65 | Leber congenital amaurosis |
| GUCY2D | Orphanet:75377 | Central areolar choroidal dystrophy |
| RP1 | Orphanet:791 | Retinitis pigmentosa |
| TULP1 | Orphanet:65 | Leber congenital amaurosis |
| TULP1 | Orphanet:791 | Retinitis pigmentosa |
| RPGRIP1 | Orphanet:1872 | Cone rod dystrophy |
| RPGRIP1 | Orphanet:564 | Meckel syndrome |
| RPGRIP1 | Orphanet:65 | Leber congenital amaurosis |
| CRB1 | Orphanet:251295 | Pigmented paravenous retinochoroidal atrophy |
| CRB1 | Orphanet:35612 | Nanophthalmos |
| CRB1 | Orphanet:65 | Leber congenital amaurosis |
| CRB1 | Orphanet:791 | Retinitis pigmentosa |
| CRX | Orphanet:1872 | Cone rod dystrophy |
| CRX | Orphanet:65 | Leber congenital amaurosis |
| CRX | Orphanet:791 | Retinitis pigmentosa |
| LCA5 | Orphanet:364055 | Severe early-childhood-onset retinal dystrophy |
| LCA5 | Orphanet:65 | Leber congenital amaurosis |
| AIPL1 | Orphanet:1872 | Cone rod dystrophy |
| AIPL1 | Orphanet:65 | Leber congenital amaurosis |
| ALOX12B | Orphanet:281122 | Self-improving collodion baby |
| ALOX12B | Orphanet:313 | Lamellar ichthyosis |
| ALOX12B | Orphanet:79394 | Congenital ichthyosiform erythroderma |
| LRAT | Orphanet:364055 | Severe early-childhood-onset retinal dystrophy |
| LRAT | Orphanet:65 | Leber congenital amaurosis |
| LRAT | Orphanet:791 | Retinitis pigmentosa |
| MAPRE2 | Orphanet:2505 | Multiple benign circumferential skin creases on limbs |
| PROM1 | Orphanet:1872 | Cone rod dystrophy |
| PROM1 | Orphanet:319640 | Retinal macular dystrophy type 2 |
| PROM1 | Orphanet:791 | Retinitis pigmentosa |
| PROM1 | Orphanet:827 | Stargardt disease |
Cohort genes → proteins
13 cohort genes, 13 distinct canonical proteins.
Evidence partition
| Subset | Genes |
|---|---|
| multi_evidence | 13 |
Cohort genes (full)
| Symbol | HGNC | Ensembl | UniProt | Name | Evidence |
|---|---|---|---|---|---|
| GUCY2D | HGNC:4689 | ENSG00000132518 | Q02846 | Retinal guanylyl cyclase 1 | gencc,clinvar |
| RP1 | HGNC:10263 | ENSG00000104237 | P56715 | Oxygen-regulated protein 1 | clinvar |
| TULP1 | HGNC:12423 | ENSG00000112041 | O00294 | Tubby-related protein 1 | clinvar |
| RPGRIP1 | HGNC:13436 | ENSG00000092200 | Q96KN7 | X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 | clinvar |
| CRB1 | HGNC:2343 | ENSG00000134376 | P82279 | Protein crumbs homolog 1 | clinvar |
| CRX | HGNC:2383 | ENSG00000105392 | O43186 | Cone-rod homeobox protein | clinvar |
| CNTROB | HGNC:29616 | ENSG00000170037 | Q8N137 | Centrobin | clinvar |
| LCA5 | HGNC:31923 | ENSG00000135338 | Q86VQ0 | Lebercilin | clinvar |
| AIPL1 | HGNC:359 | ENSG00000129221 | Q9NZN9 | Aryl-hydrocarbon-interacting protein-like 1 | clinvar |
| ALOX12B | HGNC:430 | ENSG00000179477 | O75342 | Arachidonate 12-lipoxygenase, 12R-type | clinvar |
| LRAT | HGNC:6685 | ENSG00000121207 | O95237 | Lecithin retinol acyltransferase | clinvar |
| MAPRE2 | HGNC:6891 | ENSG00000166974 | Q15555 | Microtubule-associated protein RP/EB family member 2 | clinvar |
| PROM1 | HGNC:9454 | ENSG00000007062 | O43490 | Prominin-1 | clinvar |
Cohort function summary
Lead sentence per gene, UniProt-curated.
| Symbol | Protein name | Function (lead sentence) |
|---|---|---|
| GUCY2D | Retinal guanylyl cyclase 1 | Catalyzes the synthesis of cyclic GMP (cGMP) in rods and cones of photoreceptors. |
| RP1 | Oxygen-regulated protein 1 | Microtubule-associated protein regulating the stability and length of the microtubule-based axoneme of photoreceptors. |
| TULP1 | Tubby-related protein 1 | Required for normal development of photoreceptor synapses. |
| RPGRIP1 | X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 | May function as scaffolding protein. |
| CRB1 | Protein crumbs homolog 1 | Plays a role in photoreceptor morphogenesis in the retina. |
| CRX | Cone-rod homeobox protein | Transcription factor that binds and transactivates the sequence 5’-TAATC[CA]-3’ which is found upstream of several photoreceptor-specific genes, including the opsin genes. |
| CNTROB | Centrobin | Required for centriole duplication. |
| LCA5 | Lebercilin | Involved in intraflagellar protein (IFT) transport in photoreceptor cilia. |
| AIPL1 | Aryl-hydrocarbon-interacting protein-like 1 | May be important in protein trafficking and/or protein folding and stabilization. |
| ALOX12B | Arachidonate 12-lipoxygenase, 12R-type | Catalyzes the regio and stereo-specific incorporation of a single molecule of dioxygen into free and esterified polyunsaturated fatty acids generating lipid hydroperoxides that can be further reduced to the corresponding hydroxy species. |
| LRAT | Lecithin retinol acyltransferase | Transfers the acyl group from the sn-1 position of phosphatidylcholine to all-trans retinol, producing all-trans retinyl esters. |
| MAPRE2 | Microtubule-associated protein RP/EB family member 2 | Adapter protein that is involved in microtubule polymerization, and spindle function by stabilizing microtubules and anchoring them at centrosomes. |
| PROM1 | Prominin-1 | May play a role in cell differentiation, proliferation and apoptosis. |
Protein-family classification
Druggable: 3 · Difficult: 1 · Unknown: 9 · Druggable fraction: 0.23
Family distribution
Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.
| Family | Genes | Fold | FDR |
|---|---|---|---|
| Kinase | 1 | 2.1× | 0.506 |
| Enzyme (other) | 2 | 1.8× | 0.506 |
| Other/Unknown | 9 | 1.2× | 0.506 |
| Transcription factor | 1 | 0.6× | 0.813 |
Per-gene assignment
| Symbol | Family | Druggable? | EC | InterPro (top 3) |
|---|---|---|---|---|
| GUCY2D | Kinase | yes | 4.6.1.2 | Prot_kinase_dom, A/G_cyclase, Ser-Thr/Tyr_kinase_cat_dom |
| RP1 | Other/Unknown | no | Doublecortin_dom, Doublecortin_dom_sf | |
| TULP1 | Other/Unknown | no | Tubby_C, Tubby_C_CS, Tubby-like_C | |
| RPGRIP1 | Other/Unknown | no | C2_dom, C2-C2_1, RPGRIP1_fam | |
| CRB1 | Other/Unknown | no | EGF-type_Asp/Asn_hydroxyl_site, EGF, Laminin_G | |
| CRX | Transcription factor | no | HD, Homeodomain-like_sf, Otx_TF_C | |
| CNTROB | Other/Unknown | no | Centrobin | |
| LCA5 | Other/Unknown | no | Lebercilin-like, Lebercilin_dom | |
| AIPL1 | Other/Unknown | no | TPR-like_helical_dom_sf, TPR_rpt, AIP/AIPL1/TTC9 | |
| ALOX12B | Enzyme (other) | yes | 1.13.11.31 | LipOase, PLAT/LH2_dom, LipOase_mml |
| LRAT | Enzyme (other) | yes | 2.3.1.135 | LRAT_dom, LRAT |
| MAPRE2 | Other/Unknown | no | CH_dom, EB1_C, MAPRE | |
| PROM1 | Other/Unknown | no | Prominin |
Expression context
Cohort genes with no expression data: 0.
12 cohort genes are a single-cell marker in ≥1 SCXA experiment.
Breadth distribution (Bgee present_calls)
| Bucket | Genes |
|---|---|
| narrow (1-5 tissues) | 0 |
| moderate (6-20) | 0 |
| broad (>20) | 13 |
| unknown | 0 |
Top tissues across cohort
| Tissue | Cohort genes |
|---|---|
| primordial germ cell in gonad | 3 |
| buccal mucosa cell | 2 |
| male germ line stem cell (sensu Vertebrata) in testis | 2 |
| retina | 2 |
| tendon of biceps brachii | 2 |
| left testis | 2 |
| right testis | 2 |
| ventricular zone | 2 |
| pigmented layer of retina | 2 |
| bronchial epithelial cell | 2 |
| bronchus | 2 |
| esophagus mucosa | 1 |
| lower esophagus mucosa | 1 |
| olfactory segment of nasal mucosa | 1 |
| right uterine tube | 1 |
| sperm | 1 |
| endothelial cell | 1 |
| ganglionic eminence | 1 |
| mucosa of paranasal sinus | 1 |
| pancreatic ductal cell | 1 |
Per-gene tissue summary (top 30)
| Symbol | Bgee breadth | FANTOM5 breadth | SCXA | Top tissues |
|---|---|---|---|---|
| GUCY2D | 121 | tissue_specific | marker | buccal mucosa cell, esophagus mucosa, lower esophagus mucosa |
| RP1 | 103 | tissue_specific | marker | right uterine tube, olfactory segment of nasal mucosa, male germ line stem cell (sensu Vertebrata) in testis |
| TULP1 | 134 | tissue_specific | marker | primordial germ cell in gonad, tendon of biceps brachii, retina |
| RPGRIP1 | 168 | tissue_specific | marker | left testis, sperm, right testis |
| CRB1 | 163 | broad | marker | ganglionic eminence, ventricular zone, endothelial cell |
| CRX | 54 | tissue_specific | marker | pigmented layer of retina, retina, primordial germ cell in gonad |
| CNTROB | 239 | ubiquitous | marker | left testis, right testis, ventricular zone |
| LCA5 | 214 | ubiquitous | marker | mucosa of paranasal sinus, bronchial epithelial cell, bronchus |
| AIPL1 | 62 | tissue_specific | marker | buccal mucosa cell, pancreatic ductal cell, tendon of biceps brachii |
| ALOX12B | 168 | broad | yes | skin of leg, skin of abdomen, zone of skin |
| LRAT | 149 | broad | marker | pigmented layer of retina, male germ line stem cell (sensu Vertebrata) in testis, primordial germ cell in gonad |
| MAPRE2 | 300 | ubiquitous | marker | cortical plate, dorsal root ganglion, corpus callosum |
| PROM1 | 252 | broad | marker | bronchial epithelial cell, epithelium of bronchus, bronchus |
Protein interactions among cohort
Intra-cohort edges: 20.
Hub genes (top 10 by interactor count)
| Symbol | Interactor count |
|---|---|
| PROM1 | 3,302 |
| MAPRE2 | 2,195 |
| CRX | 2,076 |
| CNTROB | 1,884 |
| RPGRIP1 | 1,422 |
| ALOX12B | 1,126 |
| GUCY2D | 1,083 |
| CRB1 | 1,075 |
| LCA5 | 1,027 |
| LRAT | 900 |
Intra-cohort edges
| A | B | Sources |
|---|---|---|
| AIPL1 | CRX | string_interaction |
| AIPL1 | GUCY2D | string_interaction |
| AIPL1 | LCA5 | string_interaction |
| AIPL1 | LRAT | string_interaction |
| AIPL1 | RPGRIP1 | string_interaction |
| AIPL1 | TULP1 | string_interaction |
| CRX | GUCY2D | string_interaction |
| CRX | LCA5 | string_interaction |
| CRX | RP1 | string_interaction |
| CRX | RPGRIP1 | string_interaction |
| CRX | TULP1 | string_interaction |
| GUCY2D | LCA5 | string_interaction |
| GUCY2D | LRAT | string_interaction |
| GUCY2D | RPGRIP1 | string_interaction |
| GUCY2D | TULP1 | string_interaction |
| LCA5 | LRAT | string_interaction |
| LCA5 | RPGRIP1 | string_interaction |
| LRAT | RPGRIP1 | string_interaction |
| LRAT | TULP1 | string_interaction |
| RPGRIP1 | TULP1 | string_interaction |
Structural data
PDB: 5 · AlphaFold-only: 8 · No structure: 0
Cohort genes with PDB structures (top 30)
| Symbol | UniProt | PDB entries |
|---|---|---|
| AIPL1 | Q9NZN9 | 6 |
| TULP1 | O00294 | 2 |
| RPGRIP1 | Q96KN7 | 1 |
| CRB1 | P82279 | 1 |
| CRX | O43186 | 1 |
AlphaFold-only cohort genes (top 30 by pLDDT)
| Symbol | UniProt | pLDDT |
|---|---|---|
| ALOX12B | O75342 | 92.07 |
| PROM1 | O43490 | 85.68 |
| LRAT | O95237 | 83.69 |
| GUCY2D | Q02846 | 82.37 |
| MAPRE2 | Q15555 | 75.12 |
| CNTROB | Q8N137 | 67.31 |
| LCA5 | Q86VQ0 | 64.05 |
| RP1 | P56715 | 37.45 |
Function
Pathway analysis
Distinct Reactome pathways touched by cohort: 18. Enrichment computed across 13 evidence-associated genes (4 with Reactome annotation).
Pathways by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 4 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| Pathway | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| Defective visual phototransduction due to LRAT loss of function | 1 | 1427.5× | 0.006 | LRAT |
| Retinoid cycle disease events | 1 | 713.8× | 0.006 | LRAT |
| Diseases associated with visual transduction | 1 | 713.8× | 0.006 | LRAT |
| Diseases of the neuronal system | 1 | 713.8× | 0.006 | LRAT |
| Synthesis of 12-eicosatetraenoic acid derivatives | 1 | 407.9× | 0.009 | ALOX12B |
| Arachidonate metabolism | 1 | 142.8× | 0.020 | ALOX12B |
| The canonical retinoid cycle in rods (twilight vision) | 1 | 129.8× | 0.020 | LRAT |
| Metabolism of fat-soluble vitamins | 1 | 95.2× | 0.024 | LRAT |
| Inactivation, recovery and regulation of the phototransduction cascade | 1 | 79.3× | 0.025 | GUCY2D |
| Visual phototransduction | 1 | 64.9× | 0.026 | LRAT |
| Retinoid metabolism and transport | 1 | 62.1× | 0.026 | LRAT |
| Developmental Lineage of Pancreatic Ductal Cells | 1 | 57.1× | 0.026 | PROM1 |
| Fatty acid metabolism | 1 | 32.8× | 0.042 | ALOX12B |
| Metabolism of vitamins and cofactors | 1 | 29.1× | 0.044 | LRAT |
| Sensory Perception | 1 | 23.8× | 0.047 | LRAT |
| Metabolism | 2 | 5.8× | 0.047 | ALOX12B, LRAT |
| Metabolism of lipids | 1 | 7.9× | 0.128 | ALOX12B |
| Disease | 1 | 3.3× | 0.273 | LRAT |
GO biological processes by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 13 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| GO term | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| visual perception | 7 | 42.8× | 6e-09 | GUCY2D, RP1, TULP1, RPGRIP1, CRX, AIPL1, LRAT |
| photoreceptor cell maintenance | 5 | 137.9× | 7e-09 | RP1, TULP1, CRB1, LCA5, PROM1 |
| regulation of opsin-mediated signaling pathway | 2 | 259.3× | 4e-04 | GUCY2D, AIPL1 |
| retinal rod cell development | 2 | 259.3× | 4e-04 | RP1, RPGRIP1 |
| retina development in camera-type eye | 3 | 58.9× | 4e-04 | RP1, TULP1, CRX |
| phototransduction, visible light | 2 | 199.4× | 6e-04 | RP1, AIPL1 |
| retina homeostasis | 2 | 172.8× | 6e-04 | TULP1, AIPL1 |
| photoreceptor cell outer segment organization | 2 | 162.0× | 6e-04 | RP1, CRB1 |
| cellular response to light stimulus | 2 | 162.0× | 6e-04 | RP1, CRB1 |
| retina layer formation | 2 | 99.7× | 0.001 | CRB1, PROM1 |
| detection of light stimulus involved in visual perception | 2 | 99.7× | 0.001 | TULP1, CRB1 |
| camera-type eye photoreceptor cell development | 1 | 1296.3× | 0.006 | CRB1 |
| positive regulation of lipid transport | 1 | 648.1× | 0.008 | LRAT |
| post-embryonic retina morphogenesis in camera-type eye | 1 | 648.1× | 0.008 | CRB1 |
| glomerular parietal epithelial cell differentiation | 1 | 648.1× | 0.008 | PROM1 |
| mitotic cytokinetic process | 1 | 648.1× | 0.008 | CNTROB |
| protein farnesylation | 1 | 432.1× | 0.010 | AIPL1 |
| positive regulation of ARF protein signal transduction | 1 | 432.1× | 0.010 | MAPRE2 |
| centrosome separation | 1 | 432.1× | 0.010 | CNTROB |
| establishment of bipolar cell polarity involved in cell morphogenesis | 1 | 432.1× | 0.010 | CRB1 |
| positive regulation of nephron tubule epithelial cell differentiation | 1 | 432.1× | 0.010 | PROM1 |
| photoreceptor cell development | 1 | 324.1× | 0.012 | RP1 |
| protein lipidation | 1 | 259.3× | 0.013 | ALOX12B |
| camera-type eye photoreceptor cell differentiation | 1 | 259.3× | 0.013 | PROM1 |
| positive regulation of mucus secretion | 1 | 259.3× | 0.013 | ALOX12B |
| vitamin A metabolic process | 1 | 185.2× | 0.017 | LRAT |
| protein localization to photoreceptor outer segment | 1 | 185.2× | 0.017 | TULP1 |
| phagocytosis, recognition | 1 | 162.0× | 0.018 | TULP1 |
| lipid oxidation | 1 | 162.0× | 0.018 | ALOX12B |
| hepoxilin biosynthetic process | 1 | 162.0× | 0.018 | ALOX12B |
Therapeutics
Drug target analysis
Approved (phase 4): 0 · Phase ≥3: 1 · Phased (≥1): 1 · Undrugged: 12
Druggability breadth: 4 of 13 evidence-associated genes (31%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).
Top cohort targets by molecule count
| Symbol | Molecules | Max phase |
|---|---|---|
| LRAT | 1 | 3 |
| GUCY2D | 0 | 0 |
| RP1 | 0 | 0 |
| TULP1 | 0 | 0 |
| RPGRIP1 | 0 | 0 |
| CRB1 | 0 | 0 |
| CRX | 0 | 0 |
| CNTROB | 0 | 0 |
| LCA5 | 0 | 0 |
| AIPL1 | 0 | 0 |
Drugs targeting cohort genes (top 30)
| Molecule | Max phase | Targets in cohort |
|---|---|---|
| FRAMYCETIN | 3 | LRAT |
Bioactivity and enzyme data
Enzyme cohort genes (≥1 EC): 3.
Cohort genes with ChEMBL bioactivity (full, sorted by assay count)
| Symbol | Assays | Type breakdown |
|---|---|---|
| RP1 | 1 | Binding:1 |
| AIPL1 | 1 | Binding:1 |
| LRAT | 1 | Binding:1 |
| MAPRE2 | 1 | Binding:1 |
Cohort enzymes (BRENDA EC)
| Symbol | EC numbers | Names |
|---|---|---|
| GUCY2D | 4.6.1.2 | guanylate cyclase |
| ALOX12B | 1.13.11.31 | arachidonate 12-lipoxygenase |
| LRAT | 2.3.1.135 | phosphatidylcholine-retinol O-acyltransferase |
Pharmacogenomics
Cohort genes with a PharmGKB record: 13; with CPIC/DPWG dosing guidelines: 0.
No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).
Chemical tractability of cohort targets
1 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.
| Compound | Max phase | Cohort target (bioactivity) |
|---|---|---|
| FRAMYCETIN | 3 | LRAT |
Druggability pyramid
Cohort genes binned by druggability tier (high → low):
| Tier | Definition | Genes | Symbols |
|---|---|---|---|
| A | Approved (phase 4 drug) | 0 | |
| B | Phased (≥1) drug, not yet approved | 1 | LRAT |
| C | Druggable family + PDB, no drug | 0 | |
| D | Druggable family + AlphaFold only, no drug | 2 | GUCY2D, ALOX12B |
| E | Difficult family or no structure, no drug | 10 | RP1, TULP1, RPGRIP1, CRB1, CRX, CNTROB, LCA5, AIPL1, MAPRE2, PROM1 |
Undrugged target profiles
12 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).
| Symbol | ChEMBL assays | Drugged partners (top 3) |
|---|---|---|
| TULP1 | 0 | LRAT |
| GUCY2D | 0 | — |
| RP1 | 1 | — |
| RPGRIP1 | 0 | — |
| CRB1 | 0 | — |
| CRX | 0 | — |
| CNTROB | 0 | — |
| LCA5 | 0 | — |
| AIPL1 | 1 | — |
| ALOX12B | 0 | — |
| MAPRE2 | 1 | — |
| PROM1 | 0 | — |
Clinical trials & evidence
Clinical trials
Clinical trials: 3.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| PHASE1 | 2 |
| PHASE1/PHASE2 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT03920007 | PHASE1/PHASE2 | ACTIVE_NOT_RECRUITING | Study of Subretinally Injected ATSN-101 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D |
| NCT01014052 | PHASE1 | COMPLETED | Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations |
| NCT01521793 | PHASE1 | COMPLETED | Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01) |
Drugs tested across these trials (top 30)
| Molecule | Max phase | Trials referencing |
|---|---|---|
| POLYMYXIN B | 4 | 1 |
| TRIMETHOPRIM | 4 | 1 |
| ZURETINOL ACETATE | 2 | 2 |
| CHEMBL15720 | 0 | 1 |
| CHEMBL2397513 | 0 | 1 |
| CHEMBL373756 | 0 | 1 |
| CHEMBL3989738 | 0 | 1 |
| CHEMBL4636958 | 0 | 1 |
| CHEMBL5281080 | 0 | 1 |